X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (124) 124
Book Review (19) 19
Newspaper Article (8) 8
Publication (8) 8
Conference Proceeding (4) 4
Book Chapter (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (71) 71
humans (66) 66
oncology (27) 27
male (25) 25
female (24) 24
cancer (21) 21
prognosis (20) 20
middle aged (19) 19
aged (17) 17
research (17) 17
pharmacology & pharmacy (16) 16
chemotherapy (15) 15
neuroblastoma (15) 15
adult (14) 14
analysis (14) 14
lung neoplasms - drug therapy (14) 14
tumors (14) 14
carcinoma, non-small-cell lung - drug therapy (13) 13
mutation (13) 13
antineoplastic agents - therapeutic use (11) 11
lung neoplasms - pathology (11) 11
neuroblastoma - genetics (11) 11
adolescent (10) 10
animals (10) 10
care and treatment (10) 10
child (10) 10
hematology (10) 10
lung cancer (10) 10
risk (10) 10
treatment outcome (10) 10
carcinoma, non-small-cell lung - pathology (9) 9
development and progression (9) 9
diagnosis (9) 9
gene expression (9) 9
genetic aspects (9) 9
nsclc (9) 9
patients (9) 9
risk factors (9) 9
gene expression profiling (8) 8
gene expression regulation, neoplastic (8) 8
genetics (8) 8
lung neoplasms - genetics (8) 8
non-small cell lung cancer (8) 8
aged, 80 and over (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
child, preschool (7) 7
expression (7) 7
immunotherapy (7) 7
lung cancer, non-small cell (7) 7
neuroblastoma - pathology (7) 7
open-label (7) 7
survival (7) 7
abridged index medicus (6) 6
antineoplastic agents - pharmacology (6) 6
biochemistry & molecular biology (6) 6
biomarkers (6) 6
cancer research (6) 6
gene (6) 6
genetics & heredity (6) 6
infant (6) 6
medicine & public health (6) 6
polymerase chain reaction (6) 6
acute myeloid-leukemia (5) 5
amplification (5) 5
biology (5) 5
biotechnology & applied microbiology (5) 5
chromosome aberrations (5) 5
disease-free survival (5) 5
drug therapy (5) 5
gene amplification (5) 5
genes (5) 5
medical research (5) 5
medulloblastoma (5) 5
medulloblastoma - genetics (5) 5
metastasis (5) 5
multivariate analysis (5) 5
mutations (5) 5
neoplasm proteins - genetics (5) 5
neoplasm staging (5) 5
nuclear proteins - genetics (5) 5
protein kinase inhibitors - therapeutic use (5) 5
research article (5) 5
time factors (5) 5
trial (5) 5
tyrosine kinase inhibitors (5) 5
usage (5) 5
1st-line treatment (4) 4
acquired-resistance (4) 4
adenocarcinoma (4) 4
afatinib (4) 4
article (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
cgh (4) 4
chemistry (4) 4
chemistry, multidisciplinary (4) 4
chromosomes (4) 4
deoxyribonucleic acid--dna (4) 4
disease (4) 4
dna (4) 4
dna mutational analysis (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 2, pp. 111 - 121
Journal Article
MOLECULAR MEDICINE, ISSN 1076-1551, 04/2019, Volume 25, Issue 1, pp. 15 - 15
Background: The demonstration of EGFR T790M gene mutation in plasma is crucial to assess the eligibility of Non Small Cell Lung Cancer (NSCLC) patients, who... 
MEDICINE, RESEARCH & EXPERIMENTAL | EGFR TKIs | GEFITINIB | OSIMERTINIB | NSCLC | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOPSY | TISSUE | Molecular tag | ACQUIRED-RESISTANCE | C797S | FACTOR-RECEPTOR MUTATIONS | Next generation sequencing | CELL BIOLOGY | PLASMA | T790M resistance mutation | Liquid biopsy | INHIBITORS | Circulating tumor DNA | AZD9291
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 06/2017, Volume 18, Issue 6, p. 1309
For the same reason, the characterization of CTCs solely using a panel of cytokeratins in non-small-cell lung cancer (NSCLC) remains a matter of debate [4]... 
Cytokeratin | Small cell lung carcinoma | Tumor cells | Lung cancer | Non-small cell lung carcinoma | Cell adhesion & migration | Chemotherapy | Morphology | Peripheral blood | Conflicts of interest | Biomarkers | 4',6-Diamidino-2-phenylindole | Immunofluorescence | Thyroid transcription factor 1 | Tumors | Thyroid | n/a
Journal Article
CANCERS, ISSN 2072-6694, 04/2019, Volume 11, Issue 4, p. 441
Women treated for breast cancer (BC) are at risk of developing secondary tumors, such as lung cancer (LC). Since rare germline variants have been linked to... 
MUTATIONAL PROCESSES | SIGNATURES | FUNCTIONAL POLYMORPHISMS | SENSITIVITY | breast cancer | RISK | multiple cancer susceptibility | GELSOLIN | lung cancer | GENETIC-VARIATION | exome sequencing | FASL CONTRIBUTE | ONCOLOGY | genetic predisposition | RADIOTHERAPY | IONIZING-RADIATION
Journal Article
Cancers, ISSN 2072-6694, 01/2019, Volume 11, Issue 1, p. 125
Nivolumab is one of the most commonly used monoclonal antibodies for advanced non-small cell lung cancer treatment, to the extent that the presence of its... 
Pharmacogenetics | Monoclonal antibody | NSCLC | Pharmacokinetics | Immunotherapy | ELISA | VARIANTS | POLYMORPHISM | DOCETAXEL | RS7041 | ONCOLOGY | RS4588 | immunotherapy | pharmacokinetics | D-BINDING PROTEIN | OUTCOMES | monoclonal antibody | pharmacogenetics
Journal Article
Infection, ISSN 0300-8126, 10/2018, Volume 46, Issue 5, pp. 607 - 615
Journal Article
JOURNAL OF CLINICAL MEDICINE, ISSN 2077-0383, 07/2019, Volume 8, Issue 7, p. 1011
The treatment of advanced non-small cell lung cancer (NSCLC) has been revolutionized by immune checkpoint inhibitors (ICIs). The identification of prognostic... 
SURVIVAL | nivolumab | PREDICTIVE BIOMARKER | EFFICACY | QUANTIFICATION | immune checkpoint inhibitors | circulating tumor cells | prognosis | CHEMOTHERAPY | lung cancer | MEDICINE, GENERAL & INTERNAL | IMMUNOTHERAPY | cell-free DNA | PD-L1 | COUNT | BLOCKADE | BURDEN | liquid biopsy
Journal Article
European Radiology, ISSN 0938-7994, 5/2019, Volume 29, Issue 5, pp. 2369 - 2377
To investigate the prognostic role of early post-infarction cardiac magnetic resonance (CMR) on long-term risk stratification of ST segment elevation... 
Medicine & Public Health | Diagnostic Radiology | Major adverse cardiovascular events | Left ventricular ejection fraction | Cardiac magnetic resonance | Microvascular obstruction | Internal Medicine | Interventional Radiology | Imaging / Radiology | Acute myocardial infarction | Ultrasound | Neuroradiology | PROGNOSTIC IMPACT | MANAGEMENT | NO-REFLOW | CARDIAC MAGNETIC-RESONANCE | SIZE | INTENSIVE-CARE UNITS | CMR | PERCUTANEOUS CORONARY INTERVENTION | ANGIOPLASTY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | LEFT-VENTRICULAR FUNCTION | Coronary Vessels - diagnostic imaging | Prognosis | Coronary Circulation - physiology | Follow-Up Studies | Coronary Vessels - physiopathology | Humans | Middle Aged | Male | ST Elevation Myocardial Infarction - diagnosis | Incidence | Microcirculation - physiology | Time Factors | Female | Ventricular Function, Left - physiology | Coronary Stenosis - epidemiology | Postoperative Complications | Survival Rate - trends | Stroke Volume - physiology | Magnetic Resonance Imaging, Cine | Disease Progression | ST Elevation Myocardial Infarction - physiopathology | Coronary Stenosis - physiopathology | ST Elevation Myocardial Infarction - surgery | Italy - epidemiology | Percutaneous Coronary Intervention - adverse effects | Coronary Stenosis - diagnosis | Heart | Myocardial infarction | Heart attacks | Magnetic resonance | Markers | Gadolinium | Risk | Tissues | Hemorrhage | Patients | Image detection | Confidence intervals | Correlation analysis | Electrocardiography | Myocardium | Infarction | Resonance | Microvasculature | Ventricle | Health risk assessment | Image enhancement | Ejection
Journal Article
Cancer Letters, ISSN 0304-3835, 2011, Volume 308, Issue 2, pp. 215 - 224
Journal Article